Global Cord Blood Corporation
CORBF
$1.02
-$0.13-11.30%
| 03/31/2022 | 09/30/2021 | 03/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -2.14% | -1.05% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -2.14% | -1.05% | |
| Cost of Revenue | -- | -- | -2.54% | -8.40% | |
| Gross Profit | -- | -- | -2.07% | 0.40% | |
| SG&A Expenses | -- | -- | -6.09% | -9.89% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | -4.35% | -9.13% | |
| Operating Income | -- | -- | 0.48% | 9.91% | |
| Income Before Tax | -- | -- | 8.57% | 6.61% | |
| Income Tax Expenses | -- | -- | -3.76% | 24.53% | |
| Earnings from Continuing Operations | -- | -- | 11.18% | 3.43% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -17.08% | -30.07% | |
| Net Income | -- | -- | 11.09% | 3.08% | |
| EBIT | -- | -- | 0.48% | 9.91% | |
| EBITDA | -- | -- | 0.40% | 8.57% | |
| EPS Basic | -- | -- | 11.15% | 3.53% | |
| Normalized Basic EPS | -- | -- | -24.98% | -16.88% | |
| EPS Diluted | -- | -- | 11.12% | 3.44% | |
| Normalized Diluted EPS | -- | -- | -24.98% | -16.88% | |
| Average Basic Shares Outstanding | -- | -- | -0.04% | -0.50% | |
| Average Diluted Shares Outstanding | -- | -- | -0.04% | -0.50% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
